[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2017 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
15-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- 12.59%
YoY- -31.04%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 1,200,652 617,923 2,323,960 1,710,764 1,136,261 618,294 2,189,022 -33.06%
PBT 40,677 28,707 73,064 53,198 37,927 27,777 72,017 -31.74%
Tax -17,322 -11,118 -17,977 -20,299 -8,918 -8,519 -26,158 -24.08%
NP 23,355 17,589 55,087 32,899 29,009 19,258 45,859 -36.30%
-
NP to SH 22,980 17,586 53,823 32,023 28,443 18,923 45,599 -36.75%
-
Tax Rate 42.58% 38.73% 24.60% 38.16% 23.51% 30.67% 36.32% -
Total Cost 1,177,297 600,334 2,268,873 1,677,865 1,107,252 599,036 2,143,163 -32.99%
-
Net Worth 519,642 524,838 526,888 531,892 541,894 544,360 531,169 -1.45%
Dividend
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Div 23,383 12,991 49,314 33,729 20,742 10,368 41,457 -31.80%
Div Payout % 101.76% 73.87% 91.62% 105.33% 72.93% 54.79% 90.92% -
Equity
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Net Worth 519,642 524,838 526,888 531,892 541,894 544,360 531,169 -1.45%
NOSH 259,821 259,821 259,821 259,821 259,279 259,219 259,377 0.11%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 1.95% 2.85% 2.37% 1.92% 2.55% 3.11% 2.09% -
ROE 4.42% 3.35% 10.22% 6.02% 5.25% 3.48% 8.58% -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 462.11 237.83 895.38 659.36 438.24 238.52 844.83 -33.19%
EPS 8.84 6.77 20.74 12.34 10.97 7.30 17.60 -36.89%
DPS 9.00 5.00 19.00 13.00 8.00 4.00 16.00 -31.92%
NAPS 2.00 2.02 2.03 2.05 2.09 2.10 2.05 -1.63%
Adjusted Per Share Value based on latest NOSH - 259,821
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 83.31 42.87 161.25 118.70 78.84 42.90 151.89 -33.06%
EPS 1.59 1.22 3.73 2.22 1.97 1.31 3.16 -36.81%
DPS 1.62 0.90 3.42 2.34 1.44 0.72 2.88 -31.92%
NAPS 0.3606 0.3642 0.3656 0.3691 0.376 0.3777 0.3686 -1.45%
Price Multiplier on Financial Quarter End Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 -
Price 2.88 4.28 4.60 4.14 4.58 4.89 5.30 -
P/RPS 0.62 1.80 0.51 0.63 1.05 2.05 0.63 -1.06%
P/EPS 32.56 63.23 22.18 33.54 41.75 66.99 30.12 5.34%
EY 3.07 1.58 4.51 2.98 2.40 1.49 3.32 -5.09%
DY 3.13 1.17 4.13 3.14 1.75 0.82 3.02 2.42%
P/NAPS 1.44 2.12 2.27 2.02 2.19 2.33 2.59 -32.45%
Price Multiplier on Announcement Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 17/08/18 16/05/18 27/02/18 15/11/17 16/08/17 16/05/17 21/02/17 -
Price 3.11 4.07 4.04 3.82 4.19 4.72 5.12 -
P/RPS 0.67 1.71 0.45 0.58 0.96 1.98 0.61 6.47%
P/EPS 35.16 60.13 19.48 30.95 38.20 64.66 29.09 13.50%
EY 2.84 1.66 5.13 3.23 2.62 1.55 3.44 -12.02%
DY 2.89 1.23 4.70 3.40 1.91 0.85 3.13 -5.19%
P/NAPS 1.56 2.01 1.99 1.86 2.00 2.25 2.50 -27.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment